Brighter expands its product portfolio – has obtained CE marking for the new device “Actiste® Mini”
Today, Brighter AB (publ) obtained EC certificates (CE marking) for its new product Actiste Mini – a smart and user-friendly blood glucose meter with global out-of-the-box connectivity through eSIM, supporting successful diabetes management and monitoring.
The new device, based on the original Actiste hardware technology platform, will be a key component in a new service currently being developed by Brighter.
“We are continuously working with IP and product development, and this is yet another project with great potential that we are proud to announce to the world. The Actiste Mini CE marking is an important milestone, and a great example of the well-functioning relationship we have established with the Notified Body. We will now be working on finalising the complete service, which is still under development, and preparing it for the market. I very much look forward to the official launch once everything is in place, says Henrik Norström, CEO of Brighter.
With Actiste Mini, and the original Actiste service aimed at insulin dependent diabetes, Brighter will be able to address the whole diabetes community.
“Although the Actiste Mini aims at a more competitive market, in comparison with Actiste, the market conditions are favorable due to the direct B2C and e-commerce opportunities within this segment,” says Henrik Norström, CEO of Brighter.
For further information, please contact:
Henrik Norström, CEO
+46 733 40 30 45
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, email@example.com, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 15:45 CET on July 7, 2020.